Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia

More Events >>

Related Tags >> H5N1 Novavax Clinical Trial Results Vaccine

preclinical News

Most Popular preclinical Story

Novavax VLP vax works against 1918 Spanish flu

April 16, 2009 — 9:04am ET | By John Carroll

Novavax says that a virus-like particle vaccine it developed was successful in guarding against both the deadly 1918 Spanish flu strain as well as an H5N1 strain in a preclinical study. Researchers Read more...

preclinical Press Releases

Novavax Announces Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against H1N1 and H5N1
ReNeuron announces positive pre-clinical data with lead stem cell line in peripheral arterial disease
Alkermes Presents Positive Preclinical Data on Molecule Designed to Improve Outcomes for Patients Taking Opiod Analgesics
Ardea Biosciences's MEK Inhibitor, RDEA119, Demonstrates Synergy with Other Anti-Cancer Agents in Multiple Tumor Types
Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies

Latest Headlines

Novavax VLP vax works against 1918 Spanish flu
April 16, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK